PMI
Picard Medical, Inc.
NYSE · Healthcare
| Dec 2024 | Dec 2025 | |
|---|---|---|
| Revenue | ||
| Revenue | 4.4M | 4.9M |
| Cost of Revenue | 4.5M | 5.1M |
| Gross Profit | -112,000 | -204,000 |
| Operating Expenses | ||
| R&D Expenses | — | — |
| SG&A Expense | — | — |
| Total Op. Expenses | — | — |
| Operating Income | -13.7M | -13.3M |
| EBITDA | -13.2M | -15.0M |
| Below the Line | ||
| Interest Expense | — | — |
| Pre-Tax Income | -21.1M | -27.0M |
| Income Tax | — | — |
| Net Income | -21.1M | -27.0M |
| Per Share | ||
| EPS (basic) | $-0.33 | $-0.75 |
| EPS (diluted) | $-0.33 | $-0.75 |
| Shares | ||
| Basic Shares | 72M | 36M |
| Diluted Shares | 72M | 36M |